Gleason Shane Thomas 4
4 · InspireMD, Inc. · Filed Jan 25, 2024
Insider Transaction Report
Form 4
InspireMD, Inc.NSPR
Gleason Shane Thomas
Chief Commercial Officer
Transactions
- Award
Common Stock
2024-01-23+238,625→ 514,365 total - Award
Options to purchase common stock (right to buy)
2024-01-23+91,218→ 183,128 totalExercise: $3.14Exp: 2034-01-23→ Common Stock (91,218 underlying)
Footnotes (2)
- [F1]These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service.
- [F2]The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service.